5 posts in this category
The evidence on accelerators is better than most people think and narrower than most people want. The useful question is which program, for which outcome.
Most of what an investor network processes is a rejection, and almost none of its process design covers one. What a usable no contains, and what silence costs.
The committee is where a deal becomes a decision. Much of what determines the outcome is process design rather than the merits of the company.
Every tool in your stack now claims AI. The label tells you nothing. Here is how to tell a bolted-on feature from a workflow that was truly built around it.
Most angel networks measure activity: deals seen, meetings held, members signed up. Here is why that misses the point, and what to track instead.